Jones offers a doctor‑recommended nicotine replacement therapy in the form of slow‑release mints that help users manage cravings and satisfy oral fixation while quitting smoking or vaping. Customers receive a personalized quit plan and access to a supportive app community that provides behavioral tools, goal tracking, and peer encouragement. The company monetizes through direct sales of the nicotine lozenge kits and subscription options for ongoing access to the digital quit‑support platform.
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Quitting nicotine is challenging, with most individuals unable to quit cold turkey due to cravings and withdrawal symptoms. Traditional methods often lack personalized support and convenient access to FDA-approved nicotine replacement therapies.
Solution
Jones provides a comprehensive, personalized nicotine replacement therapy (NRT) subscription service combined with behavioral support to improve quit rates. The platform delivers FDA-approved nicotine mints tailored to the user's dependency level, along with a mobile app that offers daily motivation, progress tracking, and community support. By addressing both the physical and psychological aspects of nicotine addiction, Jones aims to double users' chances of successfully quitting.
Target Audience
The primary target audience includes individuals over 18 who are looking to reduce or eliminate their nicotine consumption, including smokers and vapers.
Features
- Personalized quit plan based on individual nicotine dependency and goals
- Subscription delivery of FDA-approved nicotine mints
- Mobile app for habit formation, progress tracking, and community engagement
- Daily text support with tips, tricks, and motivational messages
- Doctor-recommended approach combining NRT with behavioral support
- Community forum for peer support and shared experiences